Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model

INTRODUCTION: Patients with early-onset Alzheimer's disease (EOAD) experience seizures and subclinical epileptiform activity, which may accelerate cognitive and functional decline. Antiseizure medicines (ASMs) may be a tractable disease-modifying strategy; numerous ASMs are marketed with well-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Leanne M., Barker-Haliski, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427874/
https://www.ncbi.nlm.nih.gov/pubmed/37592944
http://dx.doi.org/10.3389/fneur.2023.1223472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427874/
https://www.ncbi.nlm.nih.gov/pubmed/37592944
http://dx.doi.org/10.3389/fneur.2023.1223472

Ejemplares similares